Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 2/20 | 0.67 |
| ▸ | CDK2 | P24941 | 2/20 | 0.67 |
| ▸ | CCNK | O75909 | 1/20 | 0.67 |
| ▸ | CCND3 | P30281 | 1/20 | 0.67 |
| ▸ | CDK9 | P50750 | 1/20 | 0.67 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.67 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.65 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.65 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.65 |
| ▸ | EGFR | P00533 | 2/20 | 0.64 |
| ▸ | AURKA | O14965 | 1/20 | 0.64 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.64 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.63 |
| ▸ | PKMYT1 | Q99640 | 2/20 | 0.63 |
| ▸ | INSR | P06213 | 1/20 | 0.63 |
| ▸ | IGF1R | P08069 | 1/20 | 0.63 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.63 |
| ▸ | AXL | P30530 | 2/20 | 0.62 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.62 |
| ▸ | NEK2 | P51955 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32690403 | 0.87 | MAPK9 (0.56) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL32690420 | 0.85 | PTK2 (0.76) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL13300755 | 0.81 | CCNA2 (0.77) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL30394638 | 0.81 | CCNA2 (1.00) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL13300671 | 0.80 | PKMYT1 (0.70) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL29904658 | 0.78 | CDK9 (0.59) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL26906721 | 0.78 | CDK9 (0.59) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL15492038 | 0.78 | AURKA (1.00) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL13300736 | 0.78 | MAPK9 (0.69) | CCNA2CDK2CCNKCCND3CDK9 | |
| SCHEMBL13300660 | 0.77 | EGFR (0.73) | CCNA2CDK2CCNKCCND3CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085050-A1 | TRIPLE KINASE INHIBITORS | UNOGEN BIOTECH LTD (US) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085050-A1 | TRIPLE KINASE INHIBITORS | ALK, ERBB2, ERBB3 | CCNA2 1160/4885CDK2 66/4885CCNK 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.